IBDEI0WD ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15730,2)
 ;;=^24427
 ;;^UTILITY(U,$J,358.3,15731,0)
 ;;=380.10^^81^947^48
 ;;^UTILITY(U,$J,358.3,15731,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15731,1,4,0)
 ;;=4^380.10
 ;;^UTILITY(U,$J,358.3,15731,1,5,0)
 ;;=5^Otitis Externa 
 ;;^UTILITY(U,$J,358.3,15731,2)
 ;;=380.10^62807
 ;;^UTILITY(U,$J,358.3,15732,0)
 ;;=382.9^^81^947^49
 ;;^UTILITY(U,$J,358.3,15732,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15732,1,4,0)
 ;;=4^382.9
 ;;^UTILITY(U,$J,358.3,15732,1,5,0)
 ;;=5^Otitis Media
 ;;^UTILITY(U,$J,358.3,15732,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,15733,0)
 ;;=614.9^^81^947^50
 ;;^UTILITY(U,$J,358.3,15733,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15733,1,4,0)
 ;;=4^614.9
 ;;^UTILITY(U,$J,358.3,15733,1,5,0)
 ;;=5^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,15733,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,15734,0)
 ;;=486.^^81^947^52
 ;;^UTILITY(U,$J,358.3,15734,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15734,1,4,0)
 ;;=4^486.
 ;;^UTILITY(U,$J,358.3,15734,1,5,0)
 ;;=5^Pneumonia
 ;;^UTILITY(U,$J,358.3,15734,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,15735,0)
 ;;=136.3^^81^947^51
 ;;^UTILITY(U,$J,358.3,15735,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15735,1,4,0)
 ;;=4^136.3
 ;;^UTILITY(U,$J,358.3,15735,1,5,0)
 ;;=5^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,15735,2)
 ;;=^95635
 ;;^UTILITY(U,$J,358.3,15736,0)
 ;;=601.9^^81^947^56
 ;;^UTILITY(U,$J,358.3,15736,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15736,1,4,0)
 ;;=4^601.9
 ;;^UTILITY(U,$J,358.3,15736,1,5,0)
 ;;=5^Prostatitis NOS
 ;;^UTILITY(U,$J,358.3,15736,2)
 ;;=^99489
 ;;^UTILITY(U,$J,358.3,15737,0)
 ;;=590.80^^81^947^57
 ;;^UTILITY(U,$J,358.3,15737,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15737,1,4,0)
 ;;=4^590.80
 ;;^UTILITY(U,$J,358.3,15737,1,5,0)
 ;;=5^Pyelonephritis NOS
 ;;^UTILITY(U,$J,358.3,15737,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,15738,0)
 ;;=711.00^^81^947^58
 ;;^UTILITY(U,$J,358.3,15738,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15738,1,4,0)
 ;;=4^711.00
 ;;^UTILITY(U,$J,358.3,15738,1,5,0)
 ;;=5^Septic Joint
 ;;^UTILITY(U,$J,358.3,15738,2)
 ;;=^263780
 ;;^UTILITY(U,$J,358.3,15739,0)
 ;;=461.9^^81^947^60
 ;;^UTILITY(U,$J,358.3,15739,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15739,1,4,0)
 ;;=4^461.9
 ;;^UTILITY(U,$J,358.3,15739,1,5,0)
 ;;=5^Sinusitis, Acute
 ;;^UTILITY(U,$J,358.3,15739,2)
 ;;=^259080
 ;;^UTILITY(U,$J,358.3,15740,0)
 ;;=473.9^^81^947^59
 ;;^UTILITY(U,$J,358.3,15740,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15740,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,15740,1,5,0)
 ;;=5^Sinusitis Chronic
 ;;^UTILITY(U,$J,358.3,15740,2)
 ;;=^123985
 ;;^UTILITY(U,$J,358.3,15741,0)
 ;;=091.0^^81^947^65
 ;;^UTILITY(U,$J,358.3,15741,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15741,1,4,0)
 ;;=4^091.0
 ;;^UTILITY(U,$J,358.3,15741,1,5,0)
 ;;=5^Syphilis,Primary Genital
 ;;^UTILITY(U,$J,358.3,15741,2)
 ;;=^50581
 ;;^UTILITY(U,$J,358.3,15742,0)
 ;;=097.0^^81^947^63
 ;;^UTILITY(U,$J,358.3,15742,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15742,1,4,0)
 ;;=4^097.0
 ;;^UTILITY(U,$J,358.3,15742,1,5,0)
 ;;=5^Syphilis,Latent
 ;;^UTILITY(U,$J,358.3,15742,2)
 ;;=^266781
 ;;^UTILITY(U,$J,358.3,15743,0)
 ;;=094.9^^81^947^64
 ;;^UTILITY(U,$J,358.3,15743,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15743,1,4,0)
 ;;=4^094.9
 ;;^UTILITY(U,$J,358.3,15743,1,5,0)
 ;;=5^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,15743,2)
 ;;=^83026
 ;;^UTILITY(U,$J,358.3,15744,0)
 ;;=097.9^^81^947^62
 ;;^UTILITY(U,$J,358.3,15744,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15744,1,4,0)
 ;;=4^097.9
 ;;^UTILITY(U,$J,358.3,15744,1,5,0)
 ;;=5^Syphilis NOS
 ;;
 ;;$END ROU IBDEI0WD
